MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
Clinical trial NCT00605683 · COMPLETED
Trial details
- NCT number
- NCT00605683
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2012-01-01
- Enrollment
- 679
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.